CCO Expert Recap

Rio Update: Antiretroviral Therapy

Source: CCO Independent Conference Coverage of the 2005 International AIDS Society Conference on HIV Pathogenesis and Treatment*

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Rio Update: Antiretroviral Therapy

Program Director: John P. Phair, MD

Faculty:

Joel E. Gallant, MD, MPH

CREDIT INFORMATION

Release Date: September 23, 2005

Expiration Date: September 22, 2006

Physicians: maximum of 0.5 AMA PRA Category 1 Credits™

Status: The activity is not currently available for credit.

Learning Objectives

Upon completion of this activity, participants should be able to:

Review data on the emergence of resistance mutations during antiretroviral therapy.
Discuss data from clinical trials of agents used in first-line regimens and the role of monotherapy in the management of HIV-infected patients.
Describe the results of recent studies of novel antiretroviral agents currently in development for the treatment of HIV.

CCO Expert Recap combining slides with audio commentary by Joel E. Gallant, MD, MPH. Topics covered include:

First-line Regimens & Treatment Strategies
Insights on Immune Response
Resistance
Pharmacokinetic Studies
Novel Antiretroviral Agents

Disclaimer: The materials published on the Clinical Care Options Sites reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.